StockData
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Satellos Bioscience Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Satellos Bioscience Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Satellos Bioscience does not break out revenue by segment, region or product in the tagged data of its filings for this period type.